Document is current
Any future updates will be listed below
-
Authors
Jimenez, Veronica
Jambrina, Claudia
Casana, Estefania
Sacristan, Victor
Muñoz, Sergio
Darriba, Sara
Rodó, Jordi
Mallol, Cristina
Garcia, Miquel
León, Xavier
Marcó, Sara
Ribera, Albert
Elias, Ivet
Casellas, Alba
Grass, Ignasi
Elias, Gemma
Ferré, Tura
Motas, Sandra
Franckhauser, Sylvie
Mulero, Francisca
Navarro, Marc
Haurigot, Virginia
Ruberte, Jesus
Bosch, Fatima https://orcid.org/0000-0002-7705-5515
-
Funding
Funding for this research was provided by:
Ministerio de Economía y Competitividad (SAF2014‐54866R)
FEDER, Plan Nacional I+D+I (SAF2014‐54866R)
Generalitat de Catalunya (2014 SGR 1669)
ICREA Academia Award
European Commission (PHC‐14‐2015‐667751)
European Foundation for the Study of Diabetes
- License Information
-
More Information
Article History
Received: 18 December 2017
Revised: 8 June 2018
Accepted: 14 June 2018
First Online: 9 July 2018
Conflict of interest
: Veronica Jimenez, Claudia Jambrina, and Fatima Bosch are co‐inventors on a patent application for the use of AAV vectors for the treatment of metabolic disorders.
